Related Experiment Video
Updated: May 30, 2026
08:57
Simultaneous Measurement of Superoxide/Hydrogen Peroxide and NADH Production by Flavin-containing Mitochondrial Dehydrogenases
Published on: February 24, 2018
Structural basis for human NADPH-cytochrome P450 oxidoreductase deficiency
Chuanwu Xia1, Satya P Panda, Christopher C Marohnic
1Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Summary
NADPH-cytochrome P450 oxidoreductase (CYPOR) mutations cause instability and loss of function. Cofactor (FAD) addition can stabilize CYPOR, suggesting riboflavin therapy may treat related genetic disorders.
Area of Science:
- Biochemistry
- Structural Biology
- Genetics
Background:
- NADPH-cytochrome P450 oxidoreductase (CYPOR) is crucial for drug metabolism, steroid biosynthesis, and vitamin D/retinoic acid metabolite production.
- CYPOR's interaction with multiple redox partners makes it a model for studying protein-protein interactions.
- CYPOR gene polymorphisms are linked to bone development and steroidogenesis defects, causing sexual dimorphisms.
Purpose of the Study:
- To present the atomic structure of human CYPOR, including two missense mutations (V492E and R457H).
- To investigate the structural and functional impact of these CYPOR mutations.
- To explore potential therapeutic interventions for CYPOR dysfunction.
Main Methods:
- X-ray crystallography to determine the atomic structure of wild-type and mutant CYPOR.
- Limited trypsin digestion to analyze protein unfolding and stability.
- Biochemical assays to assess catalytic activity and cofactor binding.
Main Results:
- The structures of V492E and R457H CYPOR variants are similar to wild type but exhibit disrupted FAD binding due to altered H bonding and salt bridges.
- Both variants show reduced protein stability and loss of catalytic activity, which can be restored by adding FAD.
- V492E unfolds locally and gradually, while R457H unfolds globally, with FAD addition stabilizing both variants against trypsin digestion.
Conclusions:
- CYPOR mutations V492E and R457H impair protein stability and function by weakening FAD binding.
- FAD (cofactor) addition is critical for maintaining CYPOR structural integrity and activity.
- Riboflavin (vitamin B2) therapy could be a potential treatment for patients with these CYPOR mutations, possibly initiated prenatally or postnatally.
Related Concept Videos
01:29Role of Reduced Coenzymes NADH and FADH₂
The energy released from the breakdown of the chemical bonds within nutrients can be stored either through the reduction of electron carriers or in the bonds of adenosine triphosphate (ATP). In living systems, a small class of compounds functions as mobile electron carriers, molecules that bind to and shuttle high-energy electrons between compounds in pathways. The principal electron carriers that will be considered originate from the B vitamin group and are derivatives of nucleotides; they are...
01:27Protein Import into the Peroxisomes
Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
01:27Redox Reactions
Redox reactions are vital biochemical processes that underpin energy metabolism in cells. These reactions involve the transfer of electrons between molecules, occurring in tandem as oxidation and reduction. Oxidation refers to the loss of electrons, while reduction denotes their gain. This coupling ensures the seamless flow of electrons through metabolic pathways. For example, in bacterial metabolism, glucose undergoes oxidation to carbon dioxide, while oxygen is simultaneously reduced to...
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
01:43Electron Transport Chain: Complex III and IV
During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...
01:19Oxidation and Reduction of Organic Molecules
Energy production within a cell involves many coordinated chemical pathways. Most of these pathways are combinations of oxidation and reduction reactions, which occur at the same time. An oxidation reaction strips an electron from an atom in a compound, and the addition of this electron to another compound is a reduction reaction. Because oxidation and reduction usually occur together, these pairs of reactions are called redox reactions.
The removal of an electron from a molecule, results in a...
The removal of an electron from a molecule, results in a...